Financials data is unavailable for this security.
View more
Year on year Medicon Hellas SA had revenues remain flat at 18.12m, though the company grew net income 8.49% from 1.21m to 1.31m. A reduction in the selling, general and administrative costs as a percentage of sales from 48.94% to 47.89% was a component in the net income growth despite flat revenues.
| Gross margin | 70.53% |
|---|---|
| Net profit margin | 9.73% |
| Operating margin | 12.14% |
| Return on assets | 5.52% |
|---|---|
| Return on equity | 10.09% |
| Return on investment | 6.47% |
More ▼
Cash flow in EURView more
In 2024, Medicon Hellas SA did not generate a significant amount of cash. However, the company earned 2.00m from its operations for a Cash Flow Margin of 11.04%. In addition the company used 398.23k on investing activities and also paid 1.55m in financing cash flows.
| Cash flow per share | 0.7688 |
|---|---|
| Price/Cash flow per share | 3.11 |
| Book value per share | 4.32 |
|---|---|
| Tangible book value per share | 4.31 |
More ▼
Balance sheet in EURView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.4928 |
|---|---|
| Total debt/total capital | 0.3271 |
More ▼
Growth rates in EUR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 116.67% and 8.49%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks highest in its industry.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 31.15% |
| EPS growth(5 years) | 11.12 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 159.85 |
More ▼
